Adenovirus as an expression vector in muscle cells in vivo
about
Intramuscular electroporation with the pro-opiomelanocortin gene in rat adjuvant arthritisInsulin resistance in skeletal muscles of caveolin-3-null miceSystemic and central nervous system correction of lysosomal storage in mucopolysaccharidosis type VII miceFatty acid transport protein 1 (FATP1) localizes in mitochondria in mouse skeletal muscle and regulates lipid and ketone body disposal.Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disordersHighly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus.Adenoviral-mediated gene transfer to rabbit synovium in vivo.Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbitCellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expressionAdenovirus mediated gene transfer to skeletal muscle.Preferential and bidirectional labeling of the rubrospinal tract with adenovirus-GFP for monitoring normal and injured axons.In vivo and in vitro analysis of electrical activity-dependent expression of muscle acetylcholine receptor genes using adenovirus.Duchenne muscular dystrophy gene therapy: Lost in translation?Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo.Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapyAdenovirus-mediated expression of a voltage-gated potassium channel in vitro (rat cardiac myocytes) and in vivo (rat liver). A novel strategy for modifying excitabilityApolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectorsReduction of ethanol consumption in alcohol-preferring rats by dual expression gene transferTargeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodiesStable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus.Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigenProlonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells.Persistence in muscle of an adenoviral vector that lacks all viral genes.Co-activator binding protein PIMT mediates TNF-α induced insulin resistance in skeletal muscle via the transcriptional down-regulation of MEF2A and GLUT4.Cell engineering for muscle gene therapy: Extemporaneous production of retroviral vector packaging macrophages using defective herpes simplex virus type 1 vectors harbouring gag, pol, env genesDevelopment of approaches to improve cell survival in myoblast transfer therapy.Systemic immunological effects of cytokine genes injected into skeletal muscle.Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboonsPackaging capacity and stability of human adenovirus type 5 vectors.Novel muscle-specific enhancer sequences upstream of the cardiac actin geneQuantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo.High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles.Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral productsPlasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model.Viral Vector-Mediated Antisense Therapy for Genetic Diseases.Variables affecting in vivo performance of high-capacity adenovirus vectors.Cre-mediated somatic site-specific recombination in mice.
P2860
Q24792890-409156D4-E92C-4F55-90B5-5E92546C70D8Q28585372-569B5E54-E156-4CAB-84A9-B3CB005B7432Q33645370-72EE02EF-AB48-4CBD-9D89-42BA6240EC84Q33654802-CE24B426-BF52-465F-9D77-EEDEDC52BAEFQ33782487-F5EE0566-0585-4D68-A989-1BC17D159F2CQ33782516-516E6223-FC66-4315-908B-D21B57468810Q33808695-6FFED4DB-1347-499E-8905-2F0F8E91A705Q33985663-5E72FF91-5B54-44DF-9472-A4AA1C269875Q34113734-21F2A51F-59A8-44D0-99A6-99C239A2EA2CQ34172735-A920C7FF-9CCF-461A-8616-32FB01E67BE6Q34223710-2FEDED28-BD31-4B03-93DF-803637A9E62DQ34615481-4B294CDF-DC15-4800-9B0D-A0FCF7B62108Q34733229-91BEF7A2-4C91-4D9E-B749-9485AEA264AEQ34757639-FDA5B6DE-1E01-4C3C-9AFC-A906184AF61AQ35040707-DCA79FBF-F45C-4B0F-9B27-CB51D5A58AD4Q35052506-DFAD0387-ABA7-4164-A867-36E27CB2ABE8Q35152561-A594C573-F7F9-44C1-9B14-9E49CCC095BAQ35232341-8D13C28C-FFFD-4694-875E-81C8D970B4BDQ35753549-5FAA7FE6-6397-4B33-839F-428EF810B80BQ35763533-D317D913-5FF3-495F-B88E-BB0478A822C5Q35772588-9BCC8F43-2115-41A4-8A6B-19BD1F64EE4DQ35870207-C5C18B7F-FDB0-4820-BA4A-C2142EFD0017Q35922620-4A512ABE-F4CC-4A5B-8B88-0806E59CBF4FQ35945206-80FA5B55-E2EF-4611-AEFF-E87256DCADDAQ36014895-FE3D24AE-66F7-426B-9616-698D75FD244DQ36018705-955F94D8-2993-401D-9489-A29921196C4EQ36163897-67E03B46-48E1-4A8E-B872-8AC5A416C040Q36255482-3821AC86-8AC7-4F6D-9283-2640BD4024E5Q36290641-07A3AC37-48D2-43BE-BAB0-D1AD888623F5Q36302958-5C97BD75-63DC-48D3-8A0E-962E35885433Q36557727-BBAAA761-EAC6-4605-AF17-2BCAB1C5AD97Q36653293-A35C389E-4E2B-4B48-A2ED-26180E400866Q36653449-13F569F4-6332-4EFA-8E32-794C3476ECB4Q36709994-4B1DA47A-D44F-4503-A7A7-F2EEDEE0BB07Q37093747-72D372A1-82A2-4916-8D06-D2C919866531Q37374242-841F1A74-EAE7-4457-AF8E-F4B97C063FDDQ37383110-C10D3410-DDEA-4C75-8664-CF9CD78A98FAQ38289261-348A2653-16BB-4C50-9D14-0740EB20E76FQ39682415-6E6B6275-1406-492F-86D2-ADE0ECF17BB7Q39719850-A612E3AA-254B-4823-9F16-925DB602B798
P2860
Adenovirus as an expression vector in muscle cells in vivo
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Adenovirus as an expression vector in muscle cells in vivo
@en
type
label
Adenovirus as an expression vector in muscle cells in vivo
@en
prefLabel
Adenovirus as an expression vector in muscle cells in vivo
@en
P2093
P2860
P356
P1476
Adenovirus as an expression vector in muscle cells in vivo
@en
P2093
Perricaudet LD
Tajbakhsh S
P2860
P304
P356
10.1073/PNAS.89.7.2581
P407
P577
1992-04-01T00:00:00Z